The Patent Finder

Spotlight Therapeutics

6 applications · Updated Nov 22, 2026

Patents held now

No granted US patent is recorded under this name. The published applications below are what the record holds.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 4 abandoned

Showing 1 to 6 of 6, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page.

ApplicationTitleFiledStatus
18/640,660Guide RNAs and Uses ThereofApr 19, 2024Pending
18/481,874Adar Specific Guide RNAs and Uses ThereofOct 5, 2023Pending
18/339,859Nucleic Acid Binding Protein Formulations and Uses ThereofJun 22, 2023Abandoned
17/507,324Methods and Compositions for Nucleic Acid-Guided Nuclease Cell Targeting ScreenOct 21, 2021Abandoned
17/481,056Targeted Active Gene Editing Agent and Methods of UseSep 21, 2021Abandoned
17/480,913Targeted Active Gene Editing Agent and Methods of UseSep 21, 2021Abandoned

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited